Atorvastatin: beyond lipid-lowering effects in the diabetic population.
Statins are the mainstay of therapy in coronary artery disease and hypercholesterolemia. Atorvastatin is a 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitor that is taken once daily. It has been shown to considerably reduce cardiovascular mortality events. Recently, several trials have demonstrated that atorvastatin has pleiotropic effects beyond its lipid-lowering capacities. Atorvastatin is especially beneficial in diabetics for stroke prevention and improving cardiovascular mortality risk.
Emory University School of Medicine, Division of Cardiology, 69 Jesse Hill Drive SE, No. C247, Atlanta, GA 30303, USA.
Julie
J
Ramos
Qamar A
QA
Khan
Martin
M
Thoenes
Bobby V
BV
Khan